Total Payments
$14,055
2024 Payments
$4,525
Companies
37
Transactions
177
Medicare Patients
4,922
Medicare Billing
$284,118
Payment Breakdown by Category
Other$10,400 (74.0%)
Food & Beverage$3,295 (23.4%)
Education$227.70 (1.6%)
Travel$132.83 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,400 | 5 | 74.0% |
| Food and Beverage | $3,295 | 153 | 23.4% |
| Education | $227.70 | 16 | 1.6% |
| Travel and Lodging | $132.83 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $11,064 | 24 | $0 (2024) |
| PFIZER INC. | $664.03 | 43 | $0 (2022) |
| ABBVIE INC. | $319.49 | 18 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $241.71 | 16 | $0 (2019) |
| Renovia Inc | $161.21 | 2 | $0 (2019) |
| Myriad Women's Health, Inc. | $156.27 | 1 | $0 (2023) |
| Allergan Inc. | $152.06 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $136.13 | 8 | $0 (2019) |
| Astellas Pharma Global Development | $118.45 | 1 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $87.70 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,525 | 4 | Astellas Pharma US Inc ($4,525) |
| 2023 | $6,829 | 19 | Astellas Pharma US Inc ($6,326) |
| 2022 | $205.83 | 11 | Myovant Sciences Inc. ($43.00) |
| 2021 | $79.99 | 4 | AbbVie Inc. ($57.72) |
| 2020 | $198.68 | 11 | PFIZER INC. ($66.88) |
| 2019 | $738.94 | 37 | Renovia Inc ($161.21) |
| 2018 | $540.39 | 33 | AMAG Pharmaceuticals, Inc. ($141.77) |
| 2017 | $937.47 | 58 | PFIZER INC. ($354.16) |
All Payment Transactions
177 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 03/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Biological | ||||||
| 03/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 01/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Biological | ||||||
| 12/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.16 | General |
| Category: Biological | ||||||
| 12/09/2023 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 12/05/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Biological | ||||||
| 12/05/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Biological | ||||||
| 12/05/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $9.83 | General |
| Category: Biological | ||||||
| 11/08/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $156.27 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: HORMONE THERAPY | ||||||
| 08/23/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $19.48 | General |
| 08/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Biological | ||||||
| 08/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $65.00 | General |
| Category: Biological | ||||||
| 08/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $58.00 | General |
| Category: Biological | ||||||
| 08/02/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Endocrinology | ||||||
| 07/12/2023 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 06/14/2023 | Astellas Pharma Global Development | Veozah (Drug) | Food and Beverage | In-kind items and services | $118.45 | General |
| Category: Biological | ||||||
| 06/14/2023 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: OB/GYN | ||||||
| 06/07/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Biological | ||||||
| 04/04/2023 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device), CoolSeal Generator | Food and Beverage | In-kind items and services | $73.99 | General |
| Category: Surgical | ||||||
| 02/28/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: HORMONE THERAPY | ||||||
| 02/23/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: WOMENS HEALTH | ||||||
| 12/21/2022 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $20.99 | General |
| 10/24/2022 | Organon LLC | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,418 | 1,809 | $127,236 | $90,494 |
| 2022 | 16 | 1,179 | 1,287 | $93,012 | $65,348 |
| 2021 | 21 | 1,402 | 1,659 | $113,305 | $81,010 |
| 2020 | 16 | 923 | 1,059 | $65,495 | $47,266 |
Total Patients
4,922
Total Services
5,814
Medicare Billing
$284,118
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 566 | 566 | $27,620 | $24,098 | 87.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 231 | $25,447 | $16,048 | 63.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 176 | 176 | $9,597 | $8,374 | 87.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 132 | 168 | $11,709 | $7,379 | 63.0% |
| 90912 | Biofeedback training for bowel or bladder control, initial 15 minutes | Office | 2023 | 20 | 100 | $10,013 | $6,870 | 68.6% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 23 | 24 | $8,410 | $5,374 | 63.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 44 | 49 | $7,565 | $4,853 | 64.2% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 39 | 41 | $5,555 | $3,814 | 68.7% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Facility | 2023 | 20 | 20 | $5,575 | $3,782 | 67.8% |
| 97750 | Test or measurement for functional capacity, each 15 minutes | Office | 2023 | 26 | 125 | $5,215 | $3,547 | 68.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 19 | $2,951 | $1,743 | 59.1% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2023 | 20 | 107 | $1,865 | $1,038 | 55.7% |
| 58100 | Biopsy of lining of uterus | Office | 2023 | 15 | 15 | $1,836 | $1,021 | 55.6% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 17 | 17 | $1,352 | $923.85 | 68.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 42 | 46 | $1,345 | $837.63 | 62.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 60 | $1,047 | $658.26 | 62.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 42 | 45 | $135.00 | $132.30 | 98.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 467 | 467 | $23,950 | $20,557 | 85.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 198 | $22,885 | $13,891 | 60.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 180 | 180 | $10,243 | $8,785 | 85.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 40 | 44 | $7,219 | $4,709 | 65.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 90 | 104 | $7,583 | $4,707 | 62.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 36 | 36 | $5,199 | $3,138 | 60.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 22 | $3,570 | $2,270 | 63.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 40 | 41 | $2,053 | $1,771 | 86.3% |
About Dr. Marilyn Jerome, M.D
Dr. Marilyn Jerome, M.D is a Gynecology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558415414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marilyn Jerome, M.D has received a total of $14,055 in payments from pharmaceutical and medical device companies, with $4,525 received in 2024. These payments were reported across 177 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,400).
As a Medicare-enrolled provider, Jerome has provided services to 4,922 Medicare beneficiaries, totaling 5,814 services with total Medicare billing of $284,118. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Washington, DC
- Active Since 01/22/2007
- Last Updated 09/16/2015
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1558415414
Products in Payments
- Veozah (Drug) $10,569
- PREMARIN ORALS (Drug) $349.11
- PREMARIN (Drug) $274.72
- INTRAROSA (Drug) $211.57
- Leva Pelvic Floor Trainer (Device) $161.21
- LO LOESTRIN FE (Drug) $157.67
- MYRISK (Device) $156.27
- Orilissa (Drug) $132.56
- MYRBETRIQ (Drug) $108.23
- ORILISSA (Drug) $99.41
- MYFEMBREE (Drug) $89.44
- Osphena (Drug) $80.38
- DIVIGEL (Drug) $74.14
- ACESSA PROVU SYSTEM (Device) $73.99
- Myrbetriq (Drug) $64.66
- Mirena (Drug) $54.43
- IMVEXXY (Drug) $53.26
- Femring (Drug) $52.22
- ZOSTAVAX (Biological) $47.60
- DRG Accessories (Device) $42.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Washington
Dr. Gaby Moawad, Md, MD
Gynecology — Payments: $1.2M
Gynecology $1.2M
Dr. Anthony Scialli, Md, MD
Gynecology — Payments: $215,415
Gynecology $215,415
Dr. Andrew Goldstein, M.d, M.D
Gynecology — Payments: $87,380
Gynecology $87,380
Dr. Cheryl Iglesia, Md, MD
Gynecology — Payments: $10,045
Gynecology $10,045
Maria Vargas, Md, MD
Gynecology — Payments: $4,271
Gynecology $4,271
Dr. George Samman, M.d, M.D
Gynecology — Payments: $2,439
Gynecology $2,439